With the rising interest in biopharmaceuticals, drug developers need to quickly understand and evaluate the binding of therapeutic antibodies to Fc receptors. Learn more, in this interview with Pharmaceutical Technology, Michael Sadick, Ph.D., and Dan Papa, Ph.D., of Catalent Biologics, talk about a new analytical testing panel that can be used of this purpose.
Sadick and Papa explain how using an Octet-based Fc receptor panel may help developers achieve a faster assessment of monoclonal antibody. Read more now.
